ClinicalTrials.gg
Not yet recruitingNCT07733570Updated Jul 29, 2026

Effects of Sensory Integration Therapy in Children With Spastic Hemiplegic Cerebral Palsy

An interventional study of Sensory Integration Therapy and Conventional Physical Therapy in Spastic Hemiplegic Cerebral Palsy, sponsored by Riphah International University. Not yet recruiting. Open to participants aged 5 Years to 12 Years. Per ClinicalTrials.gov, last updated 2026-07-29.

Sponsored by Riphah International University · Not applicable, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
32
Allocation
Randomized
Ages
5 Years to 12 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 135 studies in Cerebral Palsy by Riphah International University — 37 open to participants now, 37 under way, none of them phase 3. Cerebral Palsy · Riphah International University.

Planned enrollment
52nd of 125
32 · median 30
Started
2026
with 17 others
No phase
125 of 135
34 open now
Primary completion
2027-03
later than 29 of 36 live
Registered
125th of 135
by date

Among the 135 studies in Cerebral Palsy by Riphah International University, this one is the 52nd largest by planned enrollment of the 125 interventional ones that give a count, is one of 18 that started in 2026, is one of 125 with no phase, reaches primary completion later than 29 of the 36 other live ones, and was the 125th registered.

Cerebral Palsy

1,942 studies on the registry are indexed under Cerebral Palsy; 456 are open to participants now.

Browse Cerebral Palsy studies →

Open to participants now

37 of the 135 studies in Cerebral Palsy by Riphah International University are open now, in 1 country. Recruiting first, the newest first:

32 more — sign in →

By country, each count listing its studies:

All 37 open studies →

Where they have run

Who these studies take

Of the 271 Cerebral Palsy studies recruiting now, 26 (10%) set no upper age limit and 237 (87%) stop at 75 or younger; 256 take children under 18; 53 take healthy volunteers.

This study: 5 Years to 12 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 135 studies in Cerebral Palsy by Riphah International University, or all of them as a file.
02

Study summary

The Goal of this Clinical Trial is to learn if a treatmnet called Sensory Integration Therapy (SIT) can Improve walking,Balance and movemnet in children with a type of cerebral palsy called spastic hemiplegic Cerebral Palsy .This Condition affects one side of body and make walking uneven.The study will include children between 5-12 year old .

The main Question this study aims to answer are :

Does adding SIT to regular physical therapy improve How symmetrically children walk? Does adding SIT to regular physical therapy improve balance and daily movements skills,compared with regular/conventional Physical Therapy Alone.

Researches will compare two group of children to see if SIT + Conventional Physical Therapy work better then Convential Physical therapy alone .

Participant will be palaced into one of two groups by chance one group will recieive SIT alone with COnventional PT,the other group will recieve Conventional Therapy Alone only.

Attend Therapy session 3 time a week for 8 week Be tested before and after the 8 week using simple movement and balence tests,including a walking assessment done By video .

Read the detailed description

This study is a randomized controlled trial evaluating whether Sensory Integration Therapy (SIT), when combined with conventional physiotherapy, produces greater improvements in gait symmetry, functional mobility, and balance than conventional physiotherapy alone in children aged 5-12 years with spastic hemiplegic cerebral palsy (CP).

Thirty-two participants will be recruited using non-probability consecutive sampling and then randomly allocated into two equal groups. Group A (experimental) will receive SIT (25 minutes) followed by conventional physiotherapy (20 minutes) per session. Group B (control) will receive conventional physiotherapy alone (45 minutes) per session. Both groups will attend 3 sessions per week for 8 weeks. Treatment content will progress in complexity over four two-week blocks, moving from foundational sensory and mobility activities to advanced, community-level functional tasks.

Outcomes will be assessed using three standardized tools: the Gross Motor Function Measure (GMFM-88), the Pediatric Balance Scale (PBS), and the Edinburgh Visual Gait Score (EVGS), a video-based observational gait analysis tool particularly suited to detecting asymmetry between the affected and unaffected limbs in hemiplegic CP. Assessments will be conducted at baseline and following the intervention period.

This study addresses a gap in the literature, as most prior research on SIT in CP has focused on spastic diplegic subtypes, with comparatively little evidence specific to spastic hemiplegic CP or to gait symmetry as a primary outcome. Data will be analyzed using SPSS, with a mixed-design repeated-measures ANOVA used to evaluate the effects of time, group, and the group-by-time interaction, followed by post hoc analysis where indicated.

03

Conditions studied

  • Spastic Hemiplegic Cerebral Palsy

Browse trials for

Keywords

  • Spastic hemiplegic CP
  • Gait Symmetry
  • Functional Mobility
  • Balance
  • Conventional Physical Therapy
  • Edinburg Visual Gait Score
  • Gross Motor Function Measure
  • Neurodevelopmental Rehabilitation.
04

Who can participate

Ages eligible
5 Years to 12 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Children aged 5-12 years diagnosed with spastic hemiplegic CP
  • GMFCS level I-III
  • able to follow simple commands

Exclusion criteria

Exclusion Criteria:

  • Severe cognitive impairment
  • recent orthopedic surgery
  • uncontrolled seizures.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Investigator)
Enrollment
32 participants (estimated)

Study arms

  • Experimental
    Experimental Group : SIT Plus Conventional

    Participants in this arm will receive Sensory Integration Therapy (SIT) for 25 minutes, followed by conventional physiotherapy for 20 minutes, per session. Sessions will be conducted 3 times per week for 8 weeks. SIT activities will include vestibular stimulation , proprioceptive input and tactile stimulation using varied textures, progressing over the 8 weeks to advanced sensory integration tasks, obstacle navigation, and dual-task training. Conventional physiotherapy will include stretching, range of motion exercises, sitting and standing balance training, sit-to-stand practice, and gait training, progressing to independent walking, task-oriented activities, and community mobility practice.

    Other: Sensory Integration Therapy · Other: Conventional Physical Therapy

  • Active comparator
    Control Group: Conventional Physical Therapy

    Participants in this arm will receive conventional physiotherapy only, for 45 minutes per session, 3 times per week for 8 weeks. Treatment will include stretching exercises, range of motion (ROM) exercises, sitting and standing balance training, weight shifting, and reaching activities in the early weeks, progressing to gait training, postural correction exercises, independent standing and walking practice, and functional mobility tasks. By the final weeks, sessions will include advanced gait and balance training, increased endurance activities, and community-level walking practice.

    Other: Conventional Physical Therapy

Interventions

  • OtherSensory Integration Therapy

    Sensory Integration Therapy (SIT) involved play-based sensory-motor activities targeting tactile, proprioceptive, and vestibular systems, including swinging, weight bearing, and tactile stimulation, progressing to advanced sensory tasks and dual-task training. Provided for 25 minutes per session, followed by 20 minutes of conventional physiotherapy, 3 times per week for 8 weeks.

    Also known as: Conventional physical therapy

  • OtherConventional Physical Therapy

    Participants in the control group will receive conventional physiotherapy alone, for 45 minutes per session, 3 times per week, over 8 weeks. Treatment will progress from basic stretching, range of motion exercises, and sitting/standing balance training in the early weeks, to gait training and postural correction by the middle weeks, and finally to advanced balance, endurance, and independent community-level walking practice by the final weeks. Outcomes will be assessed at baseline (Week 0) and post-intervention (Week 9) using EVGS, GMFM-88, and PBS.

06

What researchers measure

Primary outcomes

  1. Edinburgh visual gait score

    EVGS developed by Read and colleagues ,is an observational tool that evaluate gait quality in children with CP across 17 parameters and 6 body segment with score from 0-34 per limb ,where lower scores indicate near normal gait and higher score reflect greater abnormality.. It show Excellent reliability ICC of 0.947(95%) with a Cronbach's alpha value of 0.936,with minimal detectable change of 4.78 to 6.0 points.The EVGS showed good construct validity with a negative correlation with the GMFM-66 (r = -0.50 to -0.70), it also show moderate agreement 52% to 73%, with 3D gait analysis ,supporting criterion validity. In hemiplegic CP, useful for assessing gait symmetry between limbs.The maximum total Score per extermity is 34, the lower then maximum indicate less gait deviation.

    Time frame: 8 week

Secondary outcomes

  1. Gross Motor Function Measure -88(GMFM-88)

    The GMFM-88 is an observational gold standard assessment tool used to assess gross motor function in children with CP, It include 88 item/dimension that are divided into 5 areas. Each task is given a score on 4 point scale from 0 to 3,where 0 indicate the child inability to start the task at all and 3 mean the task is fully completed.GMFM-88 is a highly reliable tool with an overall ICC of 0.99 and Intra-rater reliability ranging from with ICC 0.96 and 0.99 across all five areas. Measurement Precision is supported by the SEM of 1.60 and the SRD of 3.14, reflecting stable and trustworthy results in a clinical setting. The tool showed a strong validity ,with high correlation (r = 0.82) with independent clinical judgment and good concurrent validity, with PEDI mobility domain 0.799 to 0.988

    Time frame: 8 week

  2. Pediatric Balance Scale (PBS)

    The Pediatric Balance Scale (PBS),adapted from Berg Balance Scale is design to evaluate balance in school-age children with mild to moderate motor impairment. It consist of 14 functional tasks scored on 5 point scale (0 to 4), with maximum score of 56. A higher score means better balance. The Tool show excellent reliability with test -retest ICC = 0.998 and inter-rater reliability ICC = 0.997 in children age 5 to 15 years. Items Level agreement was also strong,( kappa = 0.87 to 1.0). In spastic CP ,the PBS showed high relative reliability with satisfactory absolute reliability based ( SEM and SRD) indicating consistent and reliable results across raters and time. PBS showed a strong concurrent validity with GMFM-88 ( r = 0.926) and with GMFM-66 (r = 0.902) at baseline ,0.89-0.92 at follow up . Additionally a strong and significant co-relation with the mobility section of the PEDI (r = 0.82, p \< 0.001)in spastic CP aged 4 to 10y.

    Time frame: 8 week

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Aug 2026; primary completion for Mar 2027, 7 months later.

Of 906 non-industry interventional studies with no phase under Cerebral Palsy, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 31. This study's planned 7 months is below that.

Counting every sponsor, half of 925 studies reached it within 12 months; a quarter within 5 and three quarters within 31.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 24, 2026
First posted
Jul 29, 2026
StartEst.
Aug 22, 2026
Primary completionEst.
Mar 22, 2027
CompletionEst.
Jun 20, 2027
Last update
Jul 29, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 29, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07733570
Responsible party
Sponsor
First posted
Jul 29, 2026
Start date
Aug 22, 2026 (estimated)
Primary completion
Mar 22, 2027 (estimated)
Completion
Jun 20, 2027 (estimated)
Last update
Jul 29, 2026

Study contacts

Sidra Ghias Dr.Sidra Ghias, Phd*
Contact
sidra.ghias@riphah.edu.pk
03224356227
Arfa Murtaza, MS-PT*
principal investigator · Riphah International University ,Islamabad

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion